twitter twitter

Bio Ascend

Registration is Now Open

Registration is Now Open

Accreditation

JA Logo Commendation Mark edit2 e1748286613458

In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Bio Ascend. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIANS

The University of Nebraska Medical Center designates this live activity for a maximum of 9 AMA PRA Category 1 CreditsTM Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE

As a jointly accredited provided, the University of Nebraska Medical Center (UNMC) ensures accuracy, balance, objectivity, independence, and scientific rigor in its educational activities and is committed to protecting learners from promotion, marketing and commercial bias. All faculty, planners, and others in a position to control continuing education content participating in an accredited continuing education activity are required to disclose all financial relationships with ineligible companies. Ineligible companies are organizations whose primary business is producing, marketing, selling, and re-selling, or financial relationships in accredited continuing education. Disclosure of these commitments and/or relationships is included in these activity materials so that participants may formulate their own judgments in interpreting its content and evaluating its recommendations.

The activity may include presentation in which faculty may discuss off-label and/or investigational use of pharmaceuticals or instruments not yet FDA-approved. Participants should note that the use of products outside currently FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for FDA-approved indications. All materials are included with the permission of the faculty. The opinions expressed are those of the faculty and are not to be construed as those of UNMC or Bio Ascend.

DISCLOSURES

The accredited provided has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of the content prior to assuming their roles:

Latifat Akintade, MD

No financial relationships to disclose

Julie Brahmer, MD, MS

Consultant: Amgen, AstraZeneca, GSK, RAPT Therapeutics, Sanofi Aventis

Pelin Cinar, MD, MS

Employer: Gilead Sciences

Nazli Dizman, MD

Stock/Ownership (Significant other): Medline Global Inc.

Consultant: Eisai

Jacqueline Gaddy, MD, MSc, MSCR

No financial relationships to disclose

Joanna Ghayad, PharmD, ACC

Employee: Bristol Myers Squibb

Jennifer Grandis, MD

No financial relationships to disclose

Carmen Guerra, MD, MSCE

Member, Advisory Board: Guardant Health, Natera, Roche

Grant (Institution): Genentech

Jenna Hatcher, RN, PhD

No financial relationships to disclose

Leora Horn, MD, MSc, MHPE, FRCPC

Employee: AstraZeneca

Dame Idossa, MD

Travel: Optum Health, Bio Ascend

Consulting: Trial Library

Shivani Kapur, MD

No financial relationships to disclose

Catherine Lai, MD

Advisor: Daiichi Sankyo, Novartis, Pfizer, Taiho Oncology

Consultant/Ad Board: AbbVie, Astellas, BMS, Rigel

Ad Board: Arcellx, Servier, Syndax

Honoraria: Bio Ascend

Consultant: Genentech, Jazz Pharma, PDS Biotechnology

Deepu Madduri, MD

Employee: Johnson & Johnson

Reshma Mahtani, MD

Consultant: Agendia, Daiichi Sankyo, Eisai, Genentech, Hologic, Lilly, Merck, Novartis, Pfizer, Puma Biotechnology, Sanofi, Stemline, Sermonix Pharmaceuticals

Ariela Marshall, MD

No financial relationships to disclose

Rana McKay, MD

Consultant: Ambrx, Arcus, AstraZeneca, Aveo, Bayer, Blue Earth Diagnostics, Bristol-Myers Squibb, Calithera, Caris, Daiichi Sankyo, Dendreon, Exelixis, Johnson & Johnson, Lilly, Merck, Myovant, Neomorph, Novartis, Pfizer, Sanofi, SeaGen, Sorrento Therapeutics, Telix, Tempus

Neha Mehta-Shah, MD

Advisory Board/Consultant: Acrotech Biopharma, AstraZeneca, C4 Therapeutics, Genentech/Roche, Johnson & Johnson/Janssen, Ono Pharmaceuticals, Pfizer, Secura Bio/Red Nucleus, Verastem

Grant/Institutional Research Funding: AstraZeneca, Bristol Myers Squibb, C4 Therapeutics, Celgene, Corvus Pharmaceuticals, Daiichi Sankyo, Dizal Pharmaceuticals, Genentech/Roche, Innate Pharmaceuticals, MorphoSys, Seagen

Christiana Mo, MD

No financial relationships to disclose

Amanda Nizam, MD

Consulting or advisory role: AVEO Oncology*, Astellas Pharma, Seagen, Pfizer, EMD Serono/Merck KGaA, Formedics (formerly Mashup Media), IDEOlogy Health*, Medscape

Honoraria: Cleveland Clinic*, Aptitude Health*, Targeted Oncology*, IntegrityCE*, MECC Global Meetings, ASCO, Doximity*, Flatiron Health, SignifyMD

Bladder Cancer Section Editor: GU Oncology Now

Travel and accommodation expenses: ASCO, MECC Global Meetings, Formedics (formerly Mashup Media)

*Financial relationship ended

Coral Olazagasti, MD

Ad Board: BMS, Pfizer

Consultant: Lung Cancer Today

Sapna Patel, MD

No financial relationships to disclose

Shruti Patel, MD

No financial relationships to disclose

Elizabeth Plimack, MD

Scientific Advisory: AbbVie, AstraZeneca, BMS Eisai, EMD Serono, Flatiron, Astellas, Merck, Pfizer, SeaGen, Signatera, Synthekine, Aura Biosciences, Adaptimmune, 23andMe, Daiichi Sankyo

Gladys Rodriguez, MD

Stock ownership: Abbott Pharmaceuticals, Merck Pharmaceuticals, Novodisk

Lynn Schuchter, MD

No financial relationships to disclose

Lacey Scott Williams, MD

Consultant: Aptitude Health

Rachna Shroff, MD, MS, FASCO

Advisory Board: AstraZeneca, Boehringer Ingelheim Pharmaceuticals., Clovis, Genentech, Natera, Incyte, Merck, QED Therapeutics, Server, Zymeworks Biopharm., Astellas, Duo

Research Funding: IMV Inc., LOXO, Merck, Novocure, NUCANA, Bristol-Myers Squib, Pieris, QED Therapeutics, Seagen, Taiho, Bayer

Consulting: SYROS, Hookipa Pharma, AbbVie, Ability, Elevar Therapeutics

Surbhi Singhal, MD

Consultant: BMS, Caris Life Sciences, Oncohost

Eleonora Teplinsky, MD

Medical Advisory Board: Sermo

Consultant: AbbVie, AstraZeneca, Daiichi Sankyo, Immunogen, Novartis, Pfizer

Mazie Tsang, MD, MAS, MS

Advisory Board: AstraZeneca, Novartis, TerSera

Stock Ownership: Poseida Therapeutics

Research, Consultancy (to institution): ONO PHARMA, Eli Lilly, Genentech

Chaitra Ujjani, MD

Consultant: AbbVie, ADC Therapeutics, Alara, AstraZeneca, BeiGene, Genmab

Research: AbbVie, AstraZeneca, Lilly Pharmacyclics

Katherine Van Loon, MD, MPH

No financial relationships to disclose

Ana Velazquez Manana, MD

Consultant: AstraZeneca, BMS, Janssen, Merus, Regeneron

We use cookies for various purposes including enabling website functionality and targeted marketing activities. For more information about cookies, please review our Privacy & Cookie Notice.